ArticleCureus2026
Concurrent Acute Coronary Syndrome and Pulmonary Embolism in a Patient With Gastric Malignancy: A Diagnostic and Therapeutic Challenge.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Acute coronary syndrome (ACS) and pulmonary embolism (PE) are common, potentially life-threatening causes of acute chest pain with significant clinical overlap. Their concurrent occurrence is rare and presents important diagnostic and therapeutic challenges, particularly in patients with underlying malignancy. We report a case of a male in his 50s who presented with a two-week history of exertional chest pain and dyspnoea. Initial symptoms were attributed to iron deficiency anaemia, and subsequent outpatient investigation identified a type 1 gastric neuroendocrine tumour. He later re-presented with persistent symptoms, and further evaluation revealed bilateral pulmonary emboli and significant coronary artery disease (CAD). Management was particularly challenging given the competing risks of thrombosis and haemorrhage in the setting of active gastrointestinal malignancy. Following a multidisciplinary team discussion, percutaneous coronary intervention (PCI) was deferred until after tumour resection to mitigate bleeding risk. Following PCI, an individualised antithrombotic regimen was implemented to balance early stent protection with longer-term bleeding risk. This case demonstrates the challenges of diagnosing and managing concurrent ACS and PE in patients with gastric malignancy, highlighting the need for an individualised, multidisciplinary approach.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.